Candel Therapeutics is advancing its immunotherapy using HSV gene constructs, with clinical trials underway under FDA agreement.

The entities involved

• FDA →
  • The FDA approved Miplyffa for the treatment of Niemann-Pick disease.00:55
  • iRhythm Technologies launched its Zio ECG system in Japan following FDA clearance, amid reports that Trump-era tariffs benefit AI stocks.Fri 23:50
• Candel Therapeutics →

  company in Auburndale, United States

  Nothing else this week.

• Boston →

  capital and largest city of Massachusetts, United States

  • Heavy rains caused widespread flooding in the Boston area on November 6, 2026.00:42
  • Boston police report that criminals are arriving in the city from multiple countries including Haiti, Colombia, Ecuador, and the Dominican Republic.Fri 21:39

Related events

• Waters Corporation and LabCorp are partnering to expand access to FDA-approved HPV testing options.Oct 23
• CRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy Casgevy for sickle cell disease.Jun 22
• Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.Aug 19
• FDA granted clearance for DVT treatment involving Penumbra, Inc.Oct 22
• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7